A new research paper was published in Volume 17 of Oncotarget on March 31, 2026, titled “Efficacy and safety of PD-1/ PD-L1 ...

Antibody therapies have been used to treat diseases for nearly two decades, but their association with harmful immune ...

Treatment-related thyroid dysfunction, a common effect of PD-1 therapy, was associated with improved PFS in patients with advanced NPC.

Affirma Biotech SL has disclosed new programmed cell death 1 (PDCD1; PD-1; CD279)/PD-1 ligand 1 (PD-L1; CD274) interaction inhibitors potentially useful for the treatment of cancer, bacterial, fungal ...

In a preclinical study published in Cancer Research, researchers from the University of Texas MD Anderson Cancer Center have ...

A study reveals that nicotine triggers lung cells to release exosomes that disrupt iron balance in the brain. This lung-brain signaling pathway may contribute to neurodegeneration and cognitive ...

A manufacturing partnership enables development and clinical supply of a PD-L1-targeting therapy, supporting efficient ...

Stem cell Rx The building block of every cell, tissue, and organ in the body is the stem cell. Stem cells are ...

The entire process of atherogenesis, including initiation, growth, and complication, can be seen as an inflammatory response to injury. Factors, such as cigarette smoking, hypertension, atherogenic ...

Often confused with radiology and radiotherapy, nuclear medicine uses radioactive substances to precisely diagnose and treat ...